miR-124 exerts its tumor suppressor function by targeting cyclin-dependent kinase 6 (CDK6), and epigenetic silencing of miR-124 reportedly results in CDK6 activation and Rb phosphorylation (Lujambio et al., 2007; Agirre et al., 2009). This evidence concerns the gene CDK6 and neoplasm.